Mereo BioPharma Announces Completion of $70 Million Private Placement

    NEXT STORY
    Myriad Genetics Announces Publication of a Prospective Clinical Study of the EndoPredict® Test in Women with Early-Stage Breast Cancer
    PREV STORY
    Impact of COVID-19 on the Infectious Disease Testing Industry, 2020-2025
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    RedHill Biopharma to Present New Phase 3 Data on RHB-105 and RHB-104 at the American College of Gastroenterology 2019 Annual Meeting

    author_avatar
    NASDAQ Market News

    Relay Medical and Fio Corporation Announce Signing Distribution Partners in U.S. & France for the Fionet Mobile COVID-19 Testing and Tracking Platform

    author_avatar
    NASDAQ Market News

    Evoke Completes Phase 3 Clinical Trial of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis

    SOLANA BEACH, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), today ...

    author_avatar
    NASDAQ Market News